STAT+: Xenon’s seizure drug study reads out soon. Here’s what to expect
Stat News • 2/26/2026
Summary
Xenon Pharmaceuticals is developing a drug for the most common type of seizure experienced by people with epilepsy. A study related to this drug is expected to read out soon.
Advertisement
Lindy Score Breakdown (V4.2)
63d
Age
1
Sources
from cluster
1518
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1518/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1518/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 63 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Five-way obesity drug is super effective — in mice
Stat News • Today
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
Stat News • 2 days ago
STAT+: Google clinical director says AI can be a ‘bridge’ for people having a mental health crisis
Stat News • 2 days ago
STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
Stat News • 1 day ago
STAT+: Dems say RFK Jr. has a pattern of failing to answer their questions
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
Stat News • 2 days ago
STAT+: FDA launches effort to speed up clinical trials, using AI
Stat News • 1 day ago
STAT+: FDA wants to exclude weight-loss drugs from a compounding list
Stat News • Today
STAT+: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case
Stat News • Today
STAT+: What does Akeso’s primo plenary spot say about its survival data?
Stat News • Today